475 related articles for article (PubMed ID: 33780993)
1. [SARS-CoV-2 vaccines - what the nephrologist should know].
Heine GH; Becker SL; Scheuer AL; Schirmer SH
Dtsch Med Wochenschr; 2021 Apr; 146(7):466-470. PubMed ID: 33780993
[TBL] [Abstract][Full Text] [Related]
2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
3. Maintaining Safety with SARS-CoV-2 Vaccines.
Castells MC; Phillips EJ
N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
[No Abstract] [Full Text] [Related]
4. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
Pascolo S
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
[TBL] [Abstract][Full Text] [Related]
5. [The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines].
Windpessl M; Heine GH; Becker SL; Scheuer AL; Sester M; Kronbichler A
Dtsch Med Wochenschr; 2021 Oct; 146(19):1277-1282. PubMed ID: 34553353
[TBL] [Abstract][Full Text] [Related]
6. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
Peter J
S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
[TBL] [Abstract][Full Text] [Related]
9. [SARS-CoV-2 vaccines].
Benfield TL; Helweg-Larsen J
Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
[TBL] [Abstract][Full Text] [Related]
10. Safety of mRNA-Based Vaccines for SARS CoV-2.
Barda B; Cerny A
Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
[TBL] [Abstract][Full Text] [Related]
11. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
[No Abstract] [Full Text] [Related]
12. How COVID unlocked the power of RNA vaccines.
Dolgin E
Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
[No Abstract] [Full Text] [Related]
13. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
Russell RL; Pelka P; Mark BL
Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
[TBL] [Abstract][Full Text] [Related]
14. Lupus, vaccinations and COVID-19: What we know now.
Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
[TBL] [Abstract][Full Text] [Related]
15. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
[TBL] [Abstract][Full Text] [Related]
16. Could mixing COVID vaccines boost immune response?
Ledford H
Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
[No Abstract] [Full Text] [Related]
17. Messenger RNA vaccines against SARS-CoV-2.
Topol EJ
Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
[TBL] [Abstract][Full Text] [Related]
18. [Update 2021: COVID-19 from the perspective of nephrology].
Kann M; Benzing T
Dtsch Med Wochenschr; 2021 Jul; 146(13-14):915-917. PubMed ID: 34256408
[TBL] [Abstract][Full Text] [Related]
19. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.
Kho MML; Reinders MEJ; Baan CC; van Baarle D; Bemelman FJ; Diavatopoulos DA; Gansevoort RT; van der Klis FRM; Koopmans MPG; Messchendorp AL; van der Molen RG; Remmerswaal EBM; Rots N; Vart P; de Vries RD; Hilbrands LB; Sanders JF;
Nephrol Dial Transplant; 2021 Aug; 36(9):1761-1764. PubMed ID: 34450647
[No Abstract] [Full Text] [Related]
20. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
